Navin Fluorine International Limited manufactures fluorochemicals, specialty chemicals, contract research products, and high-performance materials. The company serves pharmaceutical, agrochemical, refrigeration, and advanced materials industries worldwide. Strong research capabilities enable development of niche high-value products. Capacity expansion supports future revenue growth. Specialty fluorochemicals remain a structural long-term growth market.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | ROE previous year | ROCE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹41,822 cr | ₹3,634 cr | ₹790 cr | 52.9 | 154.18 | 10.52 | 20.1% | 11.5% | 21.4% | 0.31 | ₹408 cr | 37.8 | 0.78 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 1,045 | 243 | 47.45 | +100.8% | +44.1% | 23.3% |
| Mar 2026 | 938 | 213 | 41.49 | +116.7% | +33.8% | 22.7% |
| Dec 2025 | 892 | 185 | 36.18 | +114.6% | +47.2% | 20.8% |
| Sep 2025 | 758 | 148 | 29.06 | +145.0% | +46.3% | 19.6% |
| Jun 2025 | 725 | 117 | 23.63 | +128.8% | +38.5% | 16.2% |
| Mar 2025 | 701 | 95 | 19.15 | +34.9% | +16.4% | 13.6% |
| Dec 2024 | 606 | 84 | 16.86 | +7.1% | +20.8% | 13.8% |
| Sep 2024 | 519 | 59 | 11.86 | -2.9% | +9.9% | 11.3% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✓ Pass |
| EPS growth accelerating over 3 quarters | ✗ Fail |
| Sales up 25%+, or sales growth accelerating | ✓ Pass |
| Annual EPS up 25%+ in each of the last 2 years | ✗ Fail |
| Net margin above the same quarter last year | ✓ Pass |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✓ Close above the 150- and 200-day averages ✓ 150-day above 200-day ✓ 200-day rising for a month ✓ 50-day above the 150- and 200-day ✗ Close above the 50-day ✓ At least 25% above the 52-week low · low 4,741.10 ✓ Within 25% of the 52-week high · high 8,775.50 ✓ RS percentile 70 or more · RS 88 Trend template - the gate, measured: a modest 21-day edge. | 7/8 | 7 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 2 - advancing | |
| CAN SLIM | ✓ C latest quarter EPS up 25%+ ✗ A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✓ N within 15% of the 52-week high · high 8,775.50 ✗ S more volume on up days than down days (50 sessions) · 0.85x ✓ L RS percentile 80 or more · RS 88 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 4/6 | Average |
| Darvas | ✓ Box top confirmed (3 sessions below the new high) · top 8,949.50 ✓ Box bottom confirmed (3 sessions holding) · bottom 8,035.00 ✗ Close above the box top · close 8,152.50 ✗ Volume at least 1.5x its 50-day average · 0.2x Nicolas Darvas's box: buy the breakout above a confirmed box after a new high. | 52/100 | In box |
| Turtle | ✗ Close above the prior 55-session high · 8,949.50 ✗ Close above the prior 20-session high · 8,682.50 ✗ Close below the prior 20-session low · 8,035.00 Donchian channel breakout - the Turtle traders' entry. | No signal | |
| Greenblatt | — Earnings yield (EBITDA / EV) · 2.6% — Return on capital (ROCE) · 21.4% Joel Greenblatt's Magic Formula: good businesses at good prices, ranked across all companies. Earnings yield uses EBITDA, as EBIT is not held separately. | 37/100 | Weak |
| Graham | ✗ Price at or below the Graham number · Graham number 1,639.62 ✗ P/E 15 or less · P/E 52.9 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 10.52 ✓ Current ratio 2 or more · 2.61 — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 20/100 | Expensive |
| Piotroski | ✓ Profitable (ROA > 0) ✓ Operating cash flow positive ✓ ROA rising ✓ Cash flow above net profit (earnings quality) ✓ Long-term debt / assets falling ✓ Current ratio rising · 2.61 ✗ No new shares issued ✓ Margin rising (net margin) ✓ Asset turnover rising Joseph Piotroski's F-score, FY 2025 -> 2026. | 8/9 | Strong |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NAVINFLUOR this stock | -5.1 | +3.7 | +26.0 | +59.6 | +123.5 | +111.1 | 52.9 | 10.52 | 20.1 | 21.4 | — | 0.31 | 37.8 | 41,822 | 3,634 | 790 | 154.2 | 0.78 |
| BODALCHEM | -14.3 | +149.1 | +142.6 | +175.9 | +104.7 | +20.3 | 30.1 | 1.78 | 4.2 | 6.7 | — | 0.69 | 14.2 | 2,065 | 2,267 | 69 | 5.5 | 0.70 |
| RPEL | +7.6 | +38.6 | +149.7 | +161.5 | — | — | 115.8 | 28.99 | 25.0 | 31.2 | — | 0.02 | 85.7 | 8,164 | 315 | 70 | 15.3 | 1.42 |
| FCL | -2.1 | +41.7 | +142.9 | +128.2 | +70.0 | +356.5 | 43.9 | 7.36 | 13.5 | 18.3 | — | 0.01 | 39.5 | 6,499 | 1,012 | 148 | 1.3 | 1.46 |
| AETHER | -6.7 | +4.9 | +28.3 | +104.1 | +70.3 | — | 85.6 | 8.22 | 9.4 | 11.6 | — | 0.18 | 55.5 | 20,191 | 1,224 | 235 | 17.8 | 0.75 |
| KRISHANA | +18.3 | +46.5 | +66.7 | +87.6 | +322.8 | +1076.5 | 33.5 | 11.74 | 38.1 | 27.3 | — | 1.31 | 22.8 | 6,581 | 2,555 | 197 | 6.4 | 1.04 |
| OAL | +21.4 | +78.0 | +98.3 | +85.2 | +69.9 | -28.9 | 395.2 | 3.16 | 0.5 | 4.5 | — | 0.61 | 32.3 | 2,101 | 1,065 | 5 | 1.6 | 0.97 |
| NEOGEN | -0.3 | +13.7 | +66.1 | +70.0 | +43.2 | +81.2 | 186.7 | 8.32 | 3.6 | 6.6 | — | 1.63 | 56.6 | 6,795 | 926 | 36 | 13.3 | 0.84 |
| VALIANTORG | +9.1 | +74.3 | +72.0 | +59.4 | -0.5 | -70.1 | 24.0 | 1.72 | 4.5 | 6.2 | — | 0.33 | 15.5 | 1,305 | 766 | 54 | 19.4 | 1.02 |
| ICIL | -5.3 | +8.0 | +58.0 | +58.8 | +74.0 | +46.7 | 55.6 | 3.56 | 5.5 | 8.7 | — | 0.46 | 21.0 | 8,394 | 4,390 | 151 | 7.6 | 1.50 |
| JGCHEM | +0.2 | +25.5 | +60.0 | +50.2 | — | — | 32.0 | 4.55 | 13.3 | 18.1 | — | 0.01 | 25.4 | 2,405 | 1,071 | 78 | 19.2 | 1.37 |